Despite a lackluster performance from Wall Street’s major indices, 10 companies demonstrated notable resilience.

Inari Medical (NARI – Research Report) received a Hold rating and price target from William Blair analyst Margaret Kaczor today. The ...

Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

Stryker (NYSE: SYK), a global leader in medical technologies, has announced its definitive agreement to acquire Inari Medical ...

The suspect in the shooting death of CEO Brian Thompson has garnered sympathy and financial support as he awaits trial, a sign that public support could sway the jury, legal analysts contend. More ...

At its height, NAIAS in Detroit was truly an international show, where anyone involved in the auto industry was expected to ...

Canaccord Genuity Group reiterated their hold rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research ...

Seed gene-editing startup Inari has completed a $144 million Series G round, bringing its cumulative funding to $720 million.